Kathryn C. Worrilow, PhD ’90, founder and CEO of LifeAire Systems, received her doctorate in Anatomy and Cell Physiology from the University of Virginia School of Medicine and completed her postdoctoral fellowship in Reproductive Physiology and Infertility at the University of Pennsylvania School of Medicine. She has served as the scientific director of In Vitro Fertilization Programs for over 20 years and has performed extensive work specific to molecular signaling between the sperm and oocyte, the contribution of the paternal genome to the embryo, and the impact of ambient air on successful human embryogenesis and preimplantation toxicology.

Her work, with that of her colleagues, led to the development and design of the LifeAire Systems patented air purification technology and System, Aire~IVF®. The Aire~IVF® System delivers the most pristine air quality available for IVF environments through an in-duct system by inactivating biologicals and eliminating embryotoxic volatile organic compounds using revolutionary and proprietary air purification technologies.

LifeAire introduced new technology that has the power to destroy the novel coronavirus, working with St. Luke’s Allentown to purify air inflow to a block of patient rooms at the height of the COVID-19 crisis.